Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Fibro-Vein 3% (150 mg/5 mL) injection, 5 mL vial |
has Australian BoSS |
True |
sodium tetradecyl sulfate |
Inferred relationship |
Some |
2139626818 |
sodium tetradecyl sulfate |
has intended active ingredient |
True |
sodium tetradecyl sulfate |
Inferred relationship |
Some |
1 |
sodium tetradecyl sulfate 0.5% (10 mg/2 mL) injection, ampoule |
has intended active ingredient |
True |
sodium tetradecyl sulfate |
Inferred relationship |
Some |
1296271454 |
sodium tetradecyl sulfate 0.5% (10 mg/2 mL) injection, ampoule |
has Australian BoSS |
True |
sodium tetradecyl sulfate |
Inferred relationship |
Some |
1296271454 |
sodium tetradecyl sulfate 1% (20 mg/2 mL) injection, ampoule |
has intended active ingredient |
True |
sodium tetradecyl sulfate |
Inferred relationship |
Some |
1800729918 |
sodium tetradecyl sulfate 1% (20 mg/2 mL) injection, ampoule |
has Australian BoSS |
True |
sodium tetradecyl sulfate |
Inferred relationship |
Some |
1800729918 |
sodium tetradecyl sulfate 3% (60 mg/2 mL) injection, ampoule |
has intended active ingredient |
True |
sodium tetradecyl sulfate |
Inferred relationship |
Some |
593416510 |
sodium tetradecyl sulfate 3% (60 mg/2 mL) injection, ampoule |
has Australian BoSS |
True |
sodium tetradecyl sulfate |
Inferred relationship |
Some |
593416510 |
sodium tetradecyl sulfate 0.2% (10 mg/5 mL) injection, vial |
has intended active ingredient |
True |
sodium tetradecyl sulfate |
Inferred relationship |
Some |
330546850 |
sodium tetradecyl sulfate 0.2% (10 mg/5 mL) injection, vial |
has Australian BoSS |
True |
sodium tetradecyl sulfate |
Inferred relationship |
Some |
330546850 |
sodium tetradecyl sulfate 3% (150 mg/5 mL) injection, vial |
has intended active ingredient |
True |
sodium tetradecyl sulfate |
Inferred relationship |
Some |
263432126 |
sodium tetradecyl sulfate 3% (150 mg/5 mL) injection, vial |
has Australian BoSS |
True |
sodium tetradecyl sulfate |
Inferred relationship |
Some |
263432126 |
Fibro-Vein 0.2% (10 mg/5 mL) injection, 5 mL vial |
has intended active ingredient |
True |
sodium tetradecyl sulfate |
Inferred relationship |
Some |
1239114910 |
Fibro-Vein 1% (20 mg/2 mL) injection, 2 mL ampoule |
has intended active ingredient |
True |
sodium tetradecyl sulfate |
Inferred relationship |
Some |
404672062 |
Fibro-Vein 0.5% (10 mg/2 mL) injection, 2 mL ampoule |
has Australian BoSS |
True |
sodium tetradecyl sulfate |
Inferred relationship |
Some |
1861499614 |
Fibro-Vein (sodium tetradecyl sulfate 60 mg / 2 mL) injection, 2 mL ampoule (trade product unit of use) |
has Australian BoSS |
True |
sodium tetradecyl sulfate |
Inferred relationship |
Some |
1735360286 |
Fibro-Vein 0.2% (10 mg/5 mL) injection, 5 mL vial |
has Australian BoSS |
True |
sodium tetradecyl sulfate |
Inferred relationship |
Some |
1239114910 |
Fibro-Vein 3% (150 mg/5 mL) injection, 5 mL vial |
has intended active ingredient |
True |
sodium tetradecyl sulfate |
Inferred relationship |
Some |
2139626818 |
Fibro-Vein 0.5% (10 mg/2 mL) injection, 2 mL ampoule |
has intended active ingredient |
True |
sodium tetradecyl sulfate |
Inferred relationship |
Some |
1861499614 |
Fibro-Vein (sodium tetradecyl sulfate 60 mg / 2 mL) injection, 2 mL ampoule (trade product unit of use) |
has intended active ingredient |
True |
sodium tetradecyl sulfate |
Inferred relationship |
Some |
1735360286 |
Fibro-Vein 1% (20 mg/2 mL) injection, 2 mL ampoule |
has Australian BoSS |
True |
sodium tetradecyl sulfate |
Inferred relationship |
Some |
404672062 |